University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Effects of Liraglutide and Fenretinide treatments on the diabetic phenotype of neuronal human BACE1 knock-in mice

Simple item page
dc.contributor.authorDekeryte, Ruta
dc.contributor.authorHull, Claire
dc.contributor.authorPlucinska, Kaja
dc.contributor.authorKhan, Shakil
dc.contributor.authorKamli-Salino, Sarah
dc.contributor.authorMody, Nimesh
dc.contributor.authorMorrice, Nicola
dc.contributor.authorMcLaughlin, Chris
dc.contributor.authorGault, Victor
dc.contributor.authorPlatt, Bettina
dc.contributor.authorDelibegovic, Mirela
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Cardiovascular and Diabetes Centreen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Medicine, Medical Sciences & Nutritionen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciences - Cardiovascular Groupen
dc.date.accessioned2020-05-15T23:05:35Z
dc.date.available2020-05-15T23:05:35Z
dc.date.issued2019-08-01
dc.descriptionThe authors would like to acknowledge University of Aberdeen PhD studentship to RD and Scottish Alzheimer’s Research UK Junior member research grant to RD to perform GLP-1 ELISA and Alzheimer’s Research UK grant to BP and MD (ARUK-PG2017B-11). We thank Dr Oliver Helk for advice concerning statistical analyses and Prof Gernot Riedel for kindly providing the PhenoTyper home cages and advice in behavioural studies.en
dc.description.statusPeer revieweden
dc.format.extent9
dc.format.extent21257242
dc.identifier144218435
dc.identifier53e93226-1927-4b39-9d74-c965b0affa90
dc.identifier85066461300
dc.identifier31103416
dc.identifier85066461300
dc.identifier000474498800021
dc.identifier.citationDekeryte, R, Hull, C, Plucinska, K, Khan, S, Kamli-Salino, S, Mody, N, Morrice, N, McLaughlin, C, Gault, V, Platt, B & Delibegovic, M 2019, 'Effects of Liraglutide and Fenretinide treatments on the diabetic phenotype of neuronal human BACE1 knock-in mice', Biochemical Pharmacology, vol. 166, pp. 222-230. https://doi.org/10.1016/j.bcp.2019.05.020, https://doi.org/10.1016/j.bcp.2019.05.020en
dc.identifier.doi10.1016/j.bcp.2019.05.020
dc.identifier.issn0006-2952
dc.identifier.otherMendeley: 197a5679-7139-360f-982e-f82868fc668a
dc.identifier.otherORCID: /0000-0002-7852-0749/work/76976903
dc.identifier.otherORCID: /0000-0002-2215-7952/work/147568359
dc.identifier.otherORCID: /0000-0002-5107-5366/work/160390078
dc.identifier.otherORCID: /0000-0001-6193-3152/work/160847650
dc.identifier.urihttps://hdl.handle.net/2164/14321
dc.identifier.urlhttps://linkinghub.elsevier.com/retrieve/pii/S0006295219301959en
dc.identifier.urlhttp://www.mendeley.com/research/effects-liraglutide-fenretinide-treatments-diabetic-phenotype-neuronal-human-bace1-knockin-miceen
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85066461300&partnerID=8YFLogxKen
dc.identifier.vol166en
dc.language.isoeng
dc.relation.ispartofBiochemical Pharmacologyen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectBACE1en
dc.subjectType 2 diabetesen
dc.subjectDPP4en
dc.subjectLiraglutideen
dc.subjectInsulin resistanceen
dc.subjectR Medicine (General)en
dc.subjectBiochemistryen
dc.subjectPharmacologyen
dc.subjectAlzheimers Research UKen
dc.subjectARUK-PG2017B-11en
dc.subject.lccR1en
dc.titleEffects of Liraglutide and Fenretinide treatments on the diabetic phenotype of neuronal human BACE1 knock-in miceen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Accepted_manuscript_May_2019.pdf
Size:
20.27 MB
Format:
Adobe Portable Document Format
Download

Collections

All research